Announcements Trials
Browse Landscape

Phase

Phase 2/3 2Phase 3 1Phase 2 1

Status

Completed 51Unknown 12Terminated 8Active not recruiting 8Recruiting 4Withdrawn 3No longer available 1

Sponsor Class

OTHER 4

Study Type

Interventional 4

Sponsor

Cancer Type

Other hematologic neoplasm 4Lymphoid 4

Conditions

Burkitt Lymphoma 9Precursor Cell Lymphoblastic Leukemia-Lymphoma 4Leukemia, Biphenotypic, Acute 3Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 2Precursor B-Cell Lymphoblastic Leukemia-Lymphoma 2Lymphoma, Extranodal NK-T-Cell 1Lymphohistiocytosis, Hemophagocytic 1Leukemia, Myeloid, Acute 1Down Syndrome 1

Interventions

Cyclophosphamide 56fludarabine 30Methotrexate 24blinatumomab 23Dexamethasone 21Cytarabine 21Vincristine 19venetoclax 18Specimen Handling 16fludarabine phosphate 15Whole-Body Irradiation 13Stem Cell Transplantation 12Biopsy 12Tacrolimus 10Mycophenolic Acid 10Immunotherapy, Adoptive 10Daunorubicin 10Thiotepa 9Rituximab 9Prednisone 9Mercaptopurine 9Melphalan 9Magnetic Resonance Spectroscopy 8Doxorubicin 8pegaspargase 7Granulocyte Colony-Stimulating Factor 7Cyclosporine 7olverembatinib 6Mesna 6Inotuzumab Ozogamicin 6

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

4 trials
RecentStart dateEnrollment
Recruiting × Precursor Cell Lymphoblastic Leukemia-Lymphoma × Asparaginase × Clear all
NCT06918431 2026-03-17

Asparaginase Erwinia Chrysanthemi With Chemotherapy for the Treatment of High-Risk Adults With Newly Diagnosed Acute Lymphoblastic Leukemia or Lymphoblastic Lymphoma

City of Hope Medical Center

Phase 2 Recruiting
53 enrolled
LymphoidOther hematologic neoplasm

Burkitt Lymphoma, Precursor Cell Lymphoblastic Leukemia-Lymphoma

NCT06855810 2025-08-26

CCCG-TALL-2025

Institute of Hematology & Blood Diseases Hospital, China

Phase 2/3 Recruiting
610 enrolled
LymphoidOther hematologic neoplasm

Precursor Cell Lymphoblastic Leukemia-Lymphoma, Precursor T-Cell Lymphoblastic Leukemia-Lymphoma

NCT06882057 2025-08-26

CCCG-LR-B-ALL

Institute of Hematology & Blood Diseases Hospital, China

Phase 2/3 Recruiting
3,000 enrolled
LymphoidOther hematologic neoplasm

Burkitt Lymphoma, Precursor Cell Lymphoblastic Leukemia-Lymphoma

NCT03643276 2025-04-06

Treatment Protocol for Children and Adolescents With Acute Lymphoblastic Leukemia - AIEOP-BFM ALL 2017

University Hospital Schleswig-Holstein

Phase 3 Recruiting
5,000 enrolled
LymphoidOther hematologic neoplasm

Precursor Cell Lymphoblastic Leukemia-Lymphoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡